Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-17

Clinical Trial Update: Concomitant Treatment with Topical Hyaluronic Acid and High Concentration Oxygen Therapy (Vaginal Natural Oxygenation Device - VNOD) in the Improvement of Symptoms Related to Genitourinary Syndrome of Menopause in Women with Natural and Oncological Postmenopause: Open-Label, Single-Center, Randomize [NA]

View source ↗

Summary

Open-label, single-center randomized trial evaluating topical hyaluronic acid in combination with the Vaginal Natural Oxygenation Device (VNOD) for genitourinar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical hyaluronic acid (hyaluronic acid)
  • Vaginal Natural Oxygenation Device (VNOD)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Genitourinary Syndrome of Menopause | NA | Status: RECRUITING